menu
    • menu

    Company profile for Xiamen Amoytop Biotech Co., Ltd

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    EXCIPIENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AMOYTOP BIOTECH, the leading manufacturer of recombinant bio-pharmaceutical products in China with cGMP, produce Molgramostim, Filgrastim, Oprelvekin, Interferon-alfa-2a, Interferon-alfa-2b, Interferon gamma, Interleukin-2, Somatropin, and provide bio-reagents, such as Interleukin-4, TNF, recombinant human SOD. AMOYTOP is also developing Y-shaped branch PEG Drug Delivery Technology in: YPeg-filgrastim, YPeginterferon-alfa-2a, ...
    AMOYTOP BIOTECH, the leading manufacturer of recombinant bio-pharmaceutical products in China with cGMP, produce Molgramostim, Filgrastim, Oprelvekin, Interferon-alfa-2a, Interferon-alfa-2b, Interferon gamma, Interleukin-2, Somatropin, and provide bio-reagents, such as Interleukin-4, TNF, recombinant human SOD. AMOYTOP is also developing Y-shaped branch PEG Drug Delivery Technology in: YPeg-filgrastim, YPeginterferon-alfa-2a, YPeg-interferon-alfa-2b, YPeg-somatropin and YPeg-EPO.AMOYTOP, the first and largest company to launch domestic Molgramostim in China, is Molgramostim Reference Standard supplier to National Institute for the Control of Pharmaceutical and Biological Products (NICPBP), China.AMOYTOP also provide service as Contract manufacturer and Contract research according to different requirements.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Xiamen Amoytop Biotech Co., LtdChina Flag
    Country
    Country
    China
    Address
    Address
    No. 330 Wengjiao Road, Xinyang Industrial Zone, Haicang
    Telephone
    Telephone
    86 592 688 9106
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.amoytop.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Drug Farm, Xiamen Amoytop Biotech Co. Sign Option for Df-006
    Drug Farm, Xiamen Amoytop Biotech Co. Sign Option for Df-006

    27 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250527594909/en/Drug-Farm-and-Xiamen-Amoytop-Biotech-Co.-Ltd.-Enter-into-Option-Agreement-for-First-In-Class-Innate-Immunity-Agonist-DF-006-to-Treat-Hepatitis-B-and-Hepatocellular-Cancer

    BUSINESSWIRE
    27 May 2025
    Share Share
    Aligos Therapeutics Announces Clinical Collaboration With Xiamen Amoytop
    Aligos Therapeutics Announces Clinical Collaboration With Xiamen Amoytop

    22 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/22/2916551/0/en/Aligos-Therapeutics-Announces-Clinical-Collaboration-with-Xiamen-Amoytop-Biotech-Co-Ltd.html

    GLOBENEWSWIRE
    22 Jul 2024
    Share Share
    Aligos Therapeutics Collaborate with Xiamen Amoytop Biotech
    Aligos Therapeutics Collaborate with Xiamen Amoytop Biotech

    15 May 2023

    // Vlad Schepkov INVESTING

    https://in.investing.com/news/aligos-therapeutics-enters-research-collaboration-and-development-agreement-with-xiamen-amoytop-biotech-for-use-of-aligos-oligonucleotide-platform-432SI-3644297

    Vlad Schepkov INVESTING
    15 May 2023
    Share Share
    Aligos Announces Research Agreement with Xiamen Amoytop
    Aligos Announces Research Agreement with Xiamen Amoytop

    12 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/12/2668190/0/en/Aligos-Therapeutics-Announces-Research-Collaboration-and-Development-Agreement-with-Xiamen-Amoytop-Biotech-Co-Ltd-for-Use-of-Aligos-Oligonucleotide-Platform-for-the-Treatment-of-Li.html

    GLOBENEWSWIRE
    12 May 2023
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search